Drugs / Dipotassium Glycyrrhizinate
last change Feb 2023 re-read 3 minutes ago

Dipotassium Glycyrrhizinate

Developed for
atopic eczema
Investigated by
The Affiliated Hospital of Xuzhou Medical University

Trials 1

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT06565117 Oct 2021 → Feb 2023 atopic eczema The Affiliated Hospital of Xuzhou Medical University Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Dipotassium Glycyrrhizinate “Efficacy of Dipotassium Glycyrrhizinate Emollients in the Maintenance Treatment of Adult Atopic Dermatitis” NCT06565117 ↗